by Pete Celano | May 28, 2025 | Uncategorized
Decompensated Cirrhosis? Some $48K per year for the average patient.Compensated Cirrhosis ? Some $36K per year for the average patient.These are numbers from 2020 (add about 4% per year in cost inflation since then, on average), from a Medicare Advantage population. A...
by Pete Celano | May 26, 2025 | Uncategorized
The article titled “Therapeutic Potential of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Liver Disease: Focus on Cirrhosis” explores the emerging role of SGLT2 inhibitors beyond their established use in managing type 2 diabetes mellitus (T2DM). It...
by Pete Celano | May 22, 2025 | Uncategorized
From the great folks at HepVu, including how to get tested– About HepVu An estimated 4 million people in the U.S. are living with Hepatitis C infection. Making data on the viral hepatitis epidemic widely available, easily accessible, and locally...
by Pete Celano | May 19, 2025 | Uncategorized
PBC is a form of liver disease that causes a backup of bile in your body. And it’s this buildup can trigger a reaction that irritates your peripheral nerves. What happens is the peripheral nerves then send sympathetic signals to the brain and trigger a need to...
by Pete Celano | May 15, 2025 | Uncategorized
Big announcement on 05/14/2025: GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for up to $2 billion.GSK plc is a British multinational pharmaceutical and biotechnology company with headquarters in London. The firm was stablished in 2000 by a merger of...
